GlassScriptPhysician profile
Timmeni Lynn Stevens
NPI 1740545722
$14,484.87
in general payments reported to CMS, 2019-2025
35 companies · $484 in 2025
The $484 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,459 · 2020: $184 · 2022: $277 · 2023: $11K · 2024: $652 · 2025: $484.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,500 · Food and Beverage: $2,829 · Travel and Lodging: $2,213 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,500.00 |
| Food and Beverage | $2,828.55 |
| Travel and Lodging | $2,213.33 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,762.16 | 2020-2024 | Davinci Xi, Da Vinci Surgical System |
| Boston Scientific Corporation | $1,199.91 | 2019 | |
| Sumitomo Pharma America, INC. | $297.70 | 2023-2025 | Myfembree, Gemtesa |
| Novo Nordisk INC | $284.38 | 2020-2024 | Wegovy, Rybelsus, Ozempic |
| Astellas Pharma US INC | $272.72 | 2023-2025 | Veozah |
| Abbvie INC. | $248.38 | 2019-2024 | |
| Sage Therapeutics, LLC | $118.95 | 2024-2025 | Zurzuvae |
| Abbott Laboratories | $116.22 | 2023-2025 | Freestyle Libre 3 |
| Pfizer INC. | $106.27 | 2023-2025 | |
| Organon LLC | $103.33 | 2023-2025 | Nexplanon, Jada System |
| Therapeuticsmd, INC. | $97.46 | 2019-2022 | |
| Exeltis, USA INC. | $84.29 | 2022-2025 | Slynd |
| Agile Therapeutics, INC. | $80.94 | 2022-2024 | Twirla |
| Exact Sciences Corporation | $79.02 | 2023-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $73.16 | 2022-2025 |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timmeni Stevens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.